BofA downgrades health care stock on fallout from Reconciliation Bill

Published 16/07/2025, 16:42
© Reuters.

Investing.com -- Bank of America downgraded multiple health care stocks, warning that recently signed U.S. legislation will trigger a reversal of years-long regulatory tailwinds, posing significant risks to growth from 2026 onward.

The bank cut HCA Healthcare (NYSE:HCA) to Neutral and downgraded Centene (NYSE:CNC), Universal Health Services (NYSE:UHS), and privately held Ardent Health to Underperform given exposure to Medicaid and exchange coverage losses stemming from the Reconciliation Bill.

The legislation introduces funding cuts that BofA said are not yet reflected in consensus estimates or share prices.

"The shift from regulatory tailwinds to regulatory headwinds on Jan 1 could be more meaningful than investors realize," analysts wrote.

While hospital fundamentals remain solid for 2025, BofA expects investor sentiment to weaken in the second half of this year as attention shifts to the longer-term impact.

The bill is projected to shave 1–3% off annual EBITDA growth for hospitals through 2030, effectively halving the sector’s historical growth rate, the note said.

Among hospitals, BofA sees HCA as relatively well-positioned but sees limited upside following recent gains.

Tenet Healthcare (NYSE:THC) remains the firm’s preferred pick due to its ambulatory surgery center business, which is largely insulated from the cuts.

For managed care, large caps such as UnitedHealth (NYSE:UNH), Cigna (NYSE:CI) and Humana (NYSE:HUM) are seen as relatively protected, but Medicaid-heavy names like Centene, Molina, and Oscar Health face steeper headwinds.

Centene, in particular, could see a 6% impact to 2027 estimates, BofA said, prompting its downgrade and estimate cuts.

Overall, the firm estimates that lost health coverage could reduce hospital volumes by 2% over five years, marking a stark reversal from the coverage-driven growth of the past decade.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.